Synsam AB (SYNSAM)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 54.10 |
|---|---|
| 52-week range | 49.80 – 70.00 |
| Return, 1 month / 3 months | +2.9% / +0.2% |
| Return, 1 year / 3 years | −1.4% / +52.5% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 28.3% |
| Worst drawdown (1 year) | -25.3% |
| Average daily value traded | 10.77M SEK |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Synsam is a Swedish optical retailer that runs a chain of stores offering eyewear and eye care services. The company sells prescription glasses, sunglasses and contact lenses, and provides eye examinations in its shops. It also offers subscription-style arrangements that combine frames, lenses and related services for customers. Synsam serves retail customers through its own store network, mainly in Sweden and elsewhere in the Nordic region, with its headquarters in Sweden.
On this site Synsam AB appears as a stock on the Stockholm Exchange (Sweden), code SYNSAM, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Synsam AB (SYNSAM) trades on the Stockholm Exchange in Sweden. It last closed at SEK 54.10 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 278 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.4% and over the last three months it rose 0.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.5% | ||
| From 52-week high | -20.4% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.2% | ||
| 6-month return | -11.6% | ||
| 12-month return, skipping the last month | -4.1% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.3% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 10.77M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +4.4% |
|---|---|
| 1 month | +2.9% |
| 3 months | +0.2% |
| 6 months | −11.6% |
| 1 year | −1.4% |
| 3 years | +52.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 54.82 / 58.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | SEK 1.8000 |
| 24 Apr 2025 | SEK 1.8000 |
| 29 Apr 2024 | SEK 1.8000 |
| 26 Apr 2023 | SEK 1.7000 |
| 27 Apr 2022 | SEK 1.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.